Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
- PMID: 16424049
- DOI: 10.1158/0008-5472.CAN-05-1299
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
Abstract
The accumulation of myeloid suppressor cells (MSCs) is associated with immune suppression in tumor-bearing mice and in cancer patients. The suppressive activity of MSC correlates with the expression of the myeloid markers Gr-1, CD115 (macrophage colony-stimulating factor receptor), and F4/80. Gr-1(+)CD115(+) MSCs, in addition to being able to suppress T-cell proliferation in vitro, can induce the development of Foxp3(+) T regulatory cells (Treg) in vivo, which are anergic and suppressive. Furthermore, the secretion of interleukin (IL)-10 and transforming growth factor-beta by Gr-1(+)CD115(+) MSCs was induced and enhanced, respectively, on IFN-gamma stimulation. The development of Treg requires antigen-associated activation of tumor-specific T cells, depends on the presence of IFN-gamma and IL-10, and is independent of the nitric oxide-mediated suppressive mechanism by MSC. Our data provide evidence that Gr-1(+)CD115(+) MSC can mediate the development of Treg in tumor-bearing mice and show a novel immune suppressive mechanism by which MSCs can suppress antitumor responses.
Similar articles
-
Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.Invest Ophthalmol Vis Sci. 2000 Mar;41(3):811-21. Invest Ophthalmol Vis Sci. 2000. PMID: 10711698
-
Analysis of splenic Gr-1int immature myeloid cells in tumor-bearing mice.Microbiol Immunol. 2008 Jan;52(1):47-53. doi: 10.1111/j.1348-0421.2008.00009.x. Microbiol Immunol. 2008. PMID: 18352913
-
Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.Int J Parasitol. 2005 Nov;35(13):1349-58. doi: 10.1016/j.ijpara.2005.06.003. Epub 2005 Jul 18. Int J Parasitol. 2005. PMID: 16126211
-
Relationship between CD4 Regulatory T Cells and Anergy In Vivo.J Immunol. 2017 Apr 1;198(7):2527-2533. doi: 10.4049/jimmunol.1602031. J Immunol. 2017. PMID: 28320913 Free PMC article. Review.
-
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms.Cell Immunol. 2017 Dec;322:1-14. doi: 10.1016/j.cellimm.2017.10.002. Epub 2017 Oct 10. Cell Immunol. 2017. PMID: 29079339 Review.
Cited by
-
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy.J Hematol Oncol. 2022 Aug 28;15(1):118. doi: 10.1186/s13045-022-01335-y. J Hematol Oncol. 2022. PMID: 36031601 Free PMC article. Review.
-
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.Adv Cancer Res. 2015;128:95-139. doi: 10.1016/bs.acr.2015.04.002. Epub 2015 May 12. Adv Cancer Res. 2015. PMID: 26216631 Free PMC article. Review.
-
Trauma equals danger--damage control by the immune system.J Leukoc Biol. 2012 Sep;92(3):539-51. doi: 10.1189/jlb.0212072. Epub 2012 May 31. J Leukoc Biol. 2012. PMID: 22654121 Free PMC article. Review.
-
New roads open up for implementing immunotherapy in mesothelioma.Clin Dev Immunol. 2012;2012:927240. doi: 10.1155/2012/927240. Epub 2012 Jun 24. Clin Dev Immunol. 2012. PMID: 22778767 Free PMC article. Review.
-
Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.Immunol Invest. 2012;41(6-7):680-710. doi: 10.3109/08820139.2012.703745. Immunol Invest. 2012. PMID: 23017141 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases